CD4 and T-cell prolymphocytic leukemia: T-cell prolymphocytic leukemia (T-PLL) is a rare and extremely aggressive disease characterized by the clonal expansion of mature CD4+ T-cells, leaving patients with limited therapeutic options and poor clinical outcomes [1].